Search
for
Sort by
Research 31–60 of 1000+
- A combined regimen of cyproterone acetate and testosterone enanthate as a potentially highly effective male contraceptive.
- [Anti-androgens. Their use in dermatology].
- Antiandrogenic therapy with ciproterone acetate in female patients who suffer from both androgenetic alopecia and acne vulgaris
- Treatment of hirsutism and acne in women with two combinations of cyproterone acetate and ethinylestradiol.
- Effectiveness of Anastrozole and Cyproterone Acetate in Two Brothers with Familial Male Precocious Puberty
- The effect of 2 combined oral Contraceptives containing either drospirenone or cyproterone acetate on acne and seborrhea.
- Pharmacology of antiandrogens
- [Clinical findings with a low-dosed antiandrogene (cyproteronacetate) and aethinyloestradiol women with virilising symptoms (author's transl)].
- Causes of hair loss and the developments in hair rejuvenation
- Androgens and Antiandrogens
- Combined oral contraceptives promote androgen receptor and oestrogen receptor alpha upregulation in the female prostate (Skene’s paraurethral glands) of adult gerbils (Meriones unguiculatus)
- Female Antiandrogens
- Hormonal Therapy for Acne
- Androgen effects on the skin
- Treatment of androgen excess in females: Yesterday, today and tomorrow
- Treatment of hyperandrogenism in women
- Diffuse hair loss in women
- Alopecia - the search for novel agents continues
- Androgen Dependence of Hirsutism, Acne, and Alopecia in Women
- Inhibition of skin 5α-reductase by oral contraceptive progestins<i>in vitro</i>
- Combined hormonal contraception and venous thromboembolism
- ANTIANDROGEN AND HORMONAL TREATMENT OF ACNE
- ANTIANDROGEN THERAPY IN DERMATOLOGY
- Endocrine evaluation of hirsutism
- Hormone therapy in acne
- Antiandrogen Therapy for Skin and Hair Disease
- Androgenic disorders of women: Diagnostic and therapeutic decision making
- Androgens and hair: a biological paradox
- Common Baldness in Women
- Effects of oral contraceptives on the quality of life of women with polycystic ovary syndrome: a crossover randomized controlled trial